The government announced on 15th that it would support the development of more than three pharmaceutical and biotechnology unicorns (unlisted companies with a corporate value of over 1 trillion ...

Carmell acquires Elevai Skincare, adding $2.5M in annual revenue and advanced exosome technology to its portfolio. Deal includes $1.1M in equity, $57K in cash, and earnouts tied to sales and ...